Jeff Yass’s Unicycive Therapeutics UNCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$624K Sell
132,830
-27,209
-17% -$141K ﹤0.01% 9140
2026
Q2
$751K Sell
160,039
-39,180
-20% -$289K ﹤0.01% 8934
2026
Q1
$1.31M Buy
199,219
+174,288
+699% +$1.14M ﹤0.01% 7208
2025
Q4
$144K Buy
+24,931
New +$133K ﹤0.01% 11205

Other funds holding UNCY

Jeff Yass's UNCY Position: Q3 2026 in Review

Jeff Yass reduced its Unicycive Therapeutics (UNCY) stake by 17% in Q3 2026, selling an estimated $141K and leaving 132,830 shares worth $624K. The position accounts for ﹤0.01% of the portfolio, ranked #9140.

Jeff Yass first reported a position in UNCY in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.31M in Q1 2026. 93 funds tracked by Wall St. Rank hold UNCY as of Q3 2026.

  • Jeff Yass held 132,830 shares of Unicycive Therapeutics worth $624K as of Q3 2026.
  • Jeff Yass sold 27,209 Unicycive Therapeutics shares in Q3 2026, an estimated $141K.
  • Unicycive Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #9140 holding.
  • Jeff Yass first reported a position in Unicycive Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • Jeff Yass's Unicycive Therapeutics position peaked at $1.31M in Q1 2026.
  • 93 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.